Literature DB >> 19505546

Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20.

Haripada Maity1, Cyrus Karkaria, Juan Davagnino.   

Abstract

This study discusses the effect of key factors like containers, buffers and the freeze (controlled vs. flash freezing) and thawing processes on the stability of a therapeutic protein fibroblast growth factor 20 (FGF-20). The freezing profiles monitored by 15 temperature probes located at different regions in a 2-L bottle during freezing can be grouped into three categories. A rapid drop in temperature was observed at the bottom followed by the top and middle center of the bottle. The freeze-thawing behavior in a 50 ml tube is considerably uniform, as expected. Among phosphate, HEPES (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid), citrate and histidine (each containing 0.5 M arginine-sulfate) buffer systems, a minimum pH change (0.4 pH unit vs. approximately 1.7 pH unit) was observed for the phosphate buffer system. Thawing in a 50 ml tube at room temperature standing resulted in a significant phase separation in citrate, histidine and HEPES buffers; however, phase separation was least in the phosphate buffer system. These phase separations were found to be temperature dependent. No effect of Polysorbate 80 on freeze-thawing of FGF-20 was observed. Significant concentration gradients in major buffer components and protein concentration were observed during freeze-thawing in a 2-L bottle. The segregation patterns of the various components were similar with the top and bottom layers containing lowest and highest concentrations, respectively. In the formulation buffer no pH gradient was formed, and the precipitation of FGF-20 during thawing at the top layer was related to an insufficient amount of arginine-sulfate and the precipitation at the bottom layer was due to a salting out effect. The precipitate generated during thawing goes into solution easily upon mixing whole solution of the bottle and the various gradient formations do not cause any irreversible change in structure, stability and isoform distribution of FGF-20. Comparison of slow freezing and flash freezing data suggests that the gradients in excipient and protein concentrations are mainly formed during thawing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505546     DOI: 10.1016/j.ijpharm.2009.05.063

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Effects of temperature and additives on stability and spectrum of a therapeutic fibroblast growth factor.

Authors:  Cy Zhou; X Guo; St Wang; Yp Zhu; Dz Mu
Journal:  Daru       Date:  2011       Impact factor: 3.117

2.  A New Approach of Extraction of α-Amylase/trypsin Inhibitors from Wheat (Triticum aestivum L.), Based on Optimization Using Plackett-Burman and Box-Behnken Designs.

Authors:  Sorel Tchewonpi Sagu; Gerd Huschek; Josephine Bönick; Thomas Homann; Harshadrai M Rawel
Journal:  Molecules       Date:  2019-10-05       Impact factor: 4.411

3.  The effect of mAb and excipient cryoconcentration on long-term frozen storage stability - part 2: Aggregate formation and oxidation.

Authors:  Oliver Bluemel; Jakob W Buecheler; Astrid Hauptmann; Georg Hoelzl; Karoline Bechtold-Peters; Wolfgang Friess
Journal:  Int J Pharm X       Date:  2021-12-25

4.  Examining the freezing process of an intermediate bulk containing an industrially relevant protein.

Authors:  Holger Reinsch; Oliver Spadiut; Johannes Heidingsfelder; Christoph Herwig
Journal:  Enzyme Microb Technol       Date:  2015-01-21       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.